Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor
出版年份 2010 全文链接
标题
Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor
作者
关键词
-
出版物
NEURO-ONCOLOGY
Volume 13, Issue 1, Pages 99-108
出版商
Oxford University Press (OUP)
发表日期
2010-12-17
DOI
10.1093/neuonc/noq170
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy
- (2009) A. K. Lucio-Eterovic et al. CLINICAL CANCER RESEARCH
- Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
- (2009) J. Felsberg et al. CLINICAL CANCER RESEARCH
- Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival
- (2009) Charlotte Aaberg-Jessen et al. JOURNAL OF NEURO-ONCOLOGY
- Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target
- (2009) Randy L. Jensen JOURNAL OF NEURO-ONCOLOGY
- Circulating endothelial progenitor cells in malignant gliomas
- (2009) Neysan Rafat et al. JOURNAL OF NEUROSURGERY
- Biomarkers of response and resistance to antiangiogenic therapy
- (2009) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Angiogenesis as a Therapeutic Target in Malignant Gliomas
- (2009) A. S. Chi et al. ONCOLOGIST
- Inhibition of Glioblastoma Growth in a Highly Invasive Nude Mouse Model Can Be Achieved by Targeting Epidermal Growth Factor Receptor but not Vascular Endothelial Growth Factor Receptor-2
- (2008) T. Martens et al. CLINICAL CANCER RESEARCH
- Pathways Mediating Resistance to Vascular Endothelial Growth Factor-Targeted Therapy
- (2008) L. M. Ellis et al. CLINICAL CANCER RESEARCH
- New molecular targets in angiogenic vessels of glioblastoma tumours
- (2008) Joshua C. Anderson et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan
- (2008) R. M. Zuniga et al. JOURNAL OF NEURO-ONCOLOGY
- Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme
- (2008) David Schiff et al. Nature clinical practice. Oncology
- Emergent unsupervised clustering paradigms with potential application to bioinformatics
- (2007) David et al. Frontiers in Bioscience-Landmark
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now